Literature DB >> 16132305

Captopril-induced pulmonary infiltrates with eosinophilia in an infant with congenital heart disease.

T C Slesnick1, A R Mott, C D Fraser, A C Chang.   

Abstract

We report a case of an infant with complex congenital heart disease who was placed on captopril for afterload reduction following cardiac surgery and subsequently developed pulmonary infiltrates with eosinophilia. The patient was readmitted with symptoms of rhinorrhea, poor feeding, and decreased activity level. She was found to have diffuse pulmonary infiltrates on chest radiograph and a marked peripheral eosinophilia without leukocytosis. After discontinuing captopril and starting systemic steroids, her symptomatology rapidly improved, and her eosinophilia and radiographic abnormalities both resolved.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16132305     DOI: 10.1007/s00246-004-0863-6

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.838


  13 in total

1.  Pulmonary eosinophilia.

Authors:  J W CROFTON; J L LIVINGSTONE; N C OSWALD; A T M ROBERTS
Journal:  Thorax       Date:  1952-03       Impact factor: 9.139

2.  Cutaneous reaction to captopril with positive patch test and lack of cross-sensitivity to enalapril and benazepril.

Authors:  M Lluch-Bernal; A Novalbos; A Umpierrez; E Figueredo; C Bombin; J Sastre
Journal:  Contact Dermatitis       Date:  1998-12       Impact factor: 6.600

3.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

Authors:  Salim Yusuf; Bertram Pitt; Clarence E Davis; William B Hood; Jay N Cohn
Journal:  N Engl J Med       Date:  1991-08-01       Impact factor: 91.245

4.  Chronic eosinophilic pneumonia.

Authors:  C B Carrington; W W Addington; A M Goff; I M Madoff; A Marks; J R Schwaber; E A Gaensler
Journal:  N Engl J Med       Date:  1969-04-10       Impact factor: 91.245

5.  Absence of cross-reactivity between captopril and enalapril.

Authors:  G J Navis; P E de Jong; C G Kallenberg; J de Monchy; D de Zeeuw
Journal:  Lancet       Date:  1984-05-05       Impact factor: 79.321

Review 6.  Drug-induced pulmonary disease. Part 2: Noncytotoxic drugs.

Authors:  J A Cooper; D A White; R A Matthay
Journal:  Am Rev Respir Dis       Date:  1986-03

Review 7.  Captopril-induced cough.

Authors:  J K Stoller; A Elghazawi; A C Mehta; D G Vidt
Journal:  Chest       Date:  1988-03       Impact factor: 9.410

8.  Captopril, an angiotensin-converting enzyme inhibitor, induced pulmonary infiltration with eosinophilia.

Authors:  K Watanabe; K Nishimura; M Shiode; M Sekiya; S Ikeda; Y Inoue; C Iwanaga
Journal:  Intern Med       Date:  1996-02       Impact factor: 1.271

9.  Captopril-induced hypersensitivity lung disease. An immune-complex-mediated phenomenon.

Authors:  P L Schatz; D Mesologites; J Hyun; G J Smith; B Lahiri
Journal:  Chest       Date:  1989-03       Impact factor: 9.410

10.  Prolonged nasal eosinophilia in allergic patients after common cold.

Authors:  I J van Benten; A KleinJan; H J Neijens; A D Osterhaus; W J Fokkens
Journal:  Allergy       Date:  2001-10       Impact factor: 13.146

View more
  1 in total

1.  ACE inhibitors: upper respiratory symptoms.

Authors:  Paulette Pinargote; Denisse Guillen; Juan C Guarderas
Journal:  BMJ Case Rep       Date:  2014-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.